Loading...
Sodium-Glucose Cotransporter 2 Inhibitors with Renoprotective Effects
BACKGROUND: Diabetes is the leading cause of end-stage renal disease (ESRD) and accounts for 40-50% of patients requiring renal replacement therapy. The main pathophysiology of diabetic nephropathy comprises glucose-dependent pathways, hemodynamic pathways, and genetic factors. SUMMARY: Glucose-depe...
Na minha lista:
| Udgivet i: | Kidney Dis (Basel) |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527177/ https://ncbi.nlm.nih.gov/pubmed/28785561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000471765 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|